AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21998095 — intervention group
Group type: COMPARATOR
Intervention: Cyclists with intact limbs
Number of subjects: 17
Study 18300900 — intervention group
Group type: EXPERIMENTAL
Intervention: External lumbar drainage (ELD) of cerebrospinal fluid (approximately 135 mL/24 h for 3 days)
Number of subjects: 18
Study 18300900 — intervention group
Group type: COMPARATOR
Intervention: Control group (matching controls)
Number of subjects: 18
Study 17136216 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg) and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Number of subjects: 20
Study 17136216 — intervention group
Group type: COMPARATOR
Intervention: Placebo and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Number of subjects: 20
Study 12655280 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management (NURS)
Number of subjects: 158
Study 12655280 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 158
Study 11015696 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UAPI) in fetuses with enlarged NT
Number of subjects: 121
Study 11015696 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UAPI) in normal karyotype fetuses with enlarged NT
Number of subjects: 121
Study 11015696 — intervention group
Group type: COMPARATOR
Intervention: Umbilical artery pulsatility index (UAPI) in normal karyotype fetuses with normal NT
Number of subjects: 121
Study 8865445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bid
Number of subjects: 142
Study 8865445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg bid
Number of subjects: 142
Study 8865445 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 142
Study 1475230 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated 500-mg naproxen tablets (fasted state)
Number of subjects: 7
Study 1475230 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated 500-mg naproxen tablets (after breakfast)
Number of subjects: 7
Study 6465056 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol
Number of subjects: 20
Study 6465056 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol acetate
Number of subjects: 20
Study 6465056 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol succinate
Number of subjects: 20
Study 6465056 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol acetate plus apple pectin
Number of subjects: 20
Study 6465056 — intervention group
Group type: EXPERIMENTAL
Intervention: all-rac-alpha-tocopheryl acetate
Number of subjects: 20
Study 31369662 — intervention group
Group type: EXPERIMENTAL
Intervention: Right dorsolateral prefrontal cortex (DLPFC) inhibitory rTMS
Number of subjects: 61
Study 29056327 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-dressed scrubs
Number of subjects: 21
Study 29056327 — intervention group
Group type: COMPARATOR
Intervention: Hospital-dressed scrubs
Number of subjects: 21
Study 27806900 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT guidance
Number of subjects: 450
Study 27806900 — intervention group
Group type: COMPARATOR
Intervention: IVUS guidance
Number of subjects: 450
Study 27806900 — intervention group
Group type: COMPARATOR
Intervention: Angiography guidance
Number of subjects: 450
Study 25358330 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg loading dose of vancomycin
Number of subjects: 99
Study 25358330 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/kg traditional dose of vancomycin
Number of subjects: 99
Study 24617225 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40
Study 24617225 — intervention group
Group type: COMPARATOR
Intervention: Medicine (dicetel and bifidobacterium lactobacillus triple viable capsules)
Number of subjects: 40
Study 21600128 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 µg/ml plus remifentanil 2.5 ng/ml
Number of subjects: 120
Study 21600128 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2 µg/ml plus remifentanil 2.0 ng/ml
Number of subjects: 120
Study 21600128 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 4 µg/ml plus remifentanil 3.0 ng/ml
Number of subjects: 120
Study 18655554 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus injection (40 mL, 10 mL containing 2 g of crude drug)
Number of subjects: 30
Study 18655554 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Astragalus injection)
Number of subjects: 30
Study 17068655 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 0
Study 17068655 — intervention group
Group type: COMPARATOR
Intervention: IntraSite Gel
Number of subjects: 0
Study 14502007 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir, stavudine and didanosine (A/S/D, n = 60)
Number of subjects: 180
Study 14502007 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir and saquinavir (R/S, n = 60)
Number of subjects: 180
Study 14502007 — intervention group
Group type: COMPARATOR
Intervention: Nelfinavir and nevirapine (N/N, n = 60)
Number of subjects: 180
Study 10918470 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (4 glasses, 40 g alcohol/day)
Number of subjects: 12
Study 10918470 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer (4 glasses, 40 g alcohol/day)
Number of subjects: 12
Study 10918470 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirits (4 glasses, 40 g alcohol/day)
Number of subjects: 12
Study 10918470 — intervention group
Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 12
Study 9175953 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding (group B)
Number of subjects: 3
Study 9175953 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula (group S)
Number of subjects: 3
Study 9175953 — intervention group
Group type: COMPARATOR
Intervention: Infant formula supplemented with nucleotides (group N)
Number of subjects: 3
Study 8157948 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with enalapril (20-40 mg once a day)
Number of subjects: 19
Study 8157948 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with enalapril
Number of subjects: 19
Study 3145964 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-interferon
Number of subjects: 89
Study 3145964 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma-interferon
Number of subjects: 89
Study 3145964 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of alpha-interferon and gamma-interferon
Number of subjects: 89
Study 31489639 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib 1 mg capsule
Number of subjects: 0
Study 31489639 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib 0.75 mg daily dose
Number of subjects: 0
Study 31489639 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib (general)
Number of subjects: 0
Study 31489639 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: DJPI (Detoxified Jatropha Protein Isolate)
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: S 75 (Soy Protein Isolate, 75% replacement)
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: S 50 (Soy Protein Isolate, 50% replacement)
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: J 75 (Jatropha Protein Isolate, 75% replacement)
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant protein-based diets (including DJPI and SPI)
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant protein-fed groups
Number of subjects: 75
Study 28900838 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 75
Study 28446537 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus clopidogrel
Number of subjects: 0
Study 28446537 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 28446537 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus placebo
Number of subjects: 0
Study 26224751 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal feeding of intact casein
Number of subjects: 11
Study 26224751 — intervention group
Group type: COMPARATOR
Intervention: Gastric feeding
Number of subjects: 11
Study 24877660 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g soy flour (whole soy group)
Number of subjects: 270
Study 24877660 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g low-fat milk powder + 63 mg daidzein (daidzein group)
Number of subjects: 270
Study 24877660 — intervention group
Group type: COMPARATOR
Intervention: 40 g low-fat milk powder (placebo group)
Number of subjects: 270
Study 23137600 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based simulation
Number of subjects: 0
Study 23137600 — intervention group
Group type: EXPERIMENTAL
Intervention: Kolb's Experiential Learning Theory (ELT)
Number of subjects: 0
Study 20512414 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg entecavir daily until October 2009 (group A)
Number of subjects: 104
Study 20512414 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg lamivudine daily until October 2009 (group B)
Number of subjects: 104
Study 20512414 — intervention group
Group type: COMPARATOR
Intervention: No nucleoside analogue (group C)
Number of subjects: 104
Study 18612729 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive web-based learning (WBL) format
Number of subjects: 122
Study 18612729 — intervention group
Group type: COMPARATOR
Intervention: Standard web-based learning (WBL) format
Number of subjects: 122
Study 16078322 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 97
Study 16078322 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy > 10 mg prednisolone equivalent per day
Number of subjects: 97
Study 16078322 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocytopenia < 600/microl
Number of subjects: 97
Study 16078322 — intervention group
Group type: EXPERIMENTAL
Intervention: T-helper lymphocytopenia < 250/microl
Number of subjects: 97
Study 11840438 — intervention group
Group type: EXPERIMENTAL
Intervention: leflunomide
Number of subjects: 39
Study 11840438 — intervention group
Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 39
Study 10636369 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation oral contraceptive (150 microg desogestrel and 30 microg ethinyloestradiol)
Number of subjects: 28
Study 10636369 — intervention group
Group type: COMPARATOR
Intervention: Second-generation oral contraceptive (150 microg levonorgestrel and 30 microg ethinyloestradiol)
Number of subjects: 28
Study 8936358 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (D-P)
Number of subjects: 67
Study 8936358 — intervention group
Group type: COMPARATOR
Intervention: Zinc sulphate (Zn)
Number of subjects: 67
Study 8936358 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (D-P) and Zinc sulphate (Zn)
Number of subjects: 67
Study 1555284 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent ST depression (STD)
Number of subjects: 261
Study 1555284 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated patients with STD
Number of subjects: 261
Study 1555284 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-treated patients with STD
Number of subjects: 261
Study 1555284 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with 1-30 minutes of STD
Number of subjects: 261
Study 1555284 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with greater than 30 minutes of STD
Number of subjects: 261
Study 3873108 — intervention group
Group type: EXPERIMENTAL
Intervention: co‐trimoxazole (800 mg sulphamethoxazole + 160 mg trimethoprim)
Number of subjects: 24
Study 3873108 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim (200 mg)
Number of subjects: 24
Study 31204264 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Shockwave Therapy (LiST)
Number of subjects: 138
Study 29402731 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic (EM) navigation system for condylar positioning
Number of subjects: 20
Study 29402731 — intervention group
Group type: COMPARATOR
Intervention: Standard manual replacement
Number of subjects: 20
Study 27063317 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 300
Study 27063317 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 300
Study 27063317 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle relaxation
Number of subjects: 300
Study 27063317 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestion therapy
Number of subjects: 300
Study 27063317 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 24885396 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubridge implantation alone or combined with bared coils
Number of subjects: 124
Study 24885396 — intervention group
Group type: COMPARATOR
Intervention: Stent‐assisted coiling (bare coils)
Number of subjects: 124
Study 21885314 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth Ball (BB) intervention during labour
Number of subjects: 58
Study 21885314 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Birth Ball)
Number of subjects: 58
Study 20166411 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-composite (Filtek Supreme XT-3M ESPE) with two-step self-etch adhesive (Adper SE Plus-3M ESPE)
Number of subjects: 60
Study 20166411 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-composite (Filtek Supreme XT-3M ESPE) with etch&rinse adhesive (Adper Single Bond 2-3M ESPE)
Number of subjects: 60
Study 20166411 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable nano-composite (Filtek Supreme XT Flow-3M ESPE) with two-step self-etch adhesive (Adper SE Plus-3M ESPE)
Number of subjects: 60
Study 20166411 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable nano-composite (Filtek Supreme XT Flow-3M ESPE) with etch&rinse adhesive (Adper Single Bond 2-3M ESPE)
Number of subjects: 60
Study 20166411 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofilled resin-modified glass ionomer (Ketac N100-3M ESPE) with Ketac Nano Primer (3M ESPE)
Number of subjects: 60
Study 17965814 — intervention group
Group type: EXPERIMENTAL
Intervention: Group caregiver education in schizophrenia
Number of subjects: 90
Study 17965814 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 15704046 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate (400 mg orally for 14 days) plus calcium (500 mg daily) and vitamin D (400 IU daily) for 76 days, repeated 8 times over 24 months
Number of subjects: 154
Study 15704046 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg daily) and vitamin D (400 IU daily) for 76 days, repeated 8 times over 24 months without etidronate
Number of subjects: 154
Study 12081675 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 U BTX‐A (50 U/ml/axilla)
Number of subjects: 18
Study 12081675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10403160 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medications
Number of subjects: 50
Study 8648964 — intervention group
Group type: EXPERIMENTAL
Intervention: Small dose kaliposol + etomidate
Number of subjects: 80
Study 8648964 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 80
Study 8263318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (mean daily dose 72 mg)
Number of subjects: 108
Study 8263318 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (mean daily dose 28 mg)
Number of subjects: 108
Study 4072939 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (240 or 360 mg/day)
Number of subjects: 20
Study 4072939 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 or 100 mg/day)
Number of subjects: 20
Study 4072939 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Diltiazem and Hydrochlorothiazide
Number of subjects: 20
Study 30843453 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg THA
Number of subjects: 159
Study 30843453 — intervention group
Group type: COMPARATOR
Intervention: 40 mg THA
Number of subjects: 159
Study 29465273 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Intervention-Problem Solving (TIPS) for nine months
Number of subjects: 87
Study 29465273 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) antipsychotic delivery
Number of subjects: 87
Study 27833863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation for 12 months
Number of subjects: 120
Study 27833863 — intervention group
Group type: COMPARATOR
Intervention: Intubation for less than 12 months
Number of subjects: 120
Study 27833863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation for more than 12 months
Number of subjects: 120
Study 27833863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation for more than 18 months
Number of subjects: 120
Study 24743584 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane via Penthrox inhaler
Number of subjects: 300
Study 24743584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 22755270 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 ml of 4 mg 0.5% hyperbaric bupivacaine
Number of subjects: 45
Study 22755270 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3-ml solution of 4 mg 0.5% hyperbaric bupivacaine + 25 microg of fentanyl
Number of subjects: 45
Study 22755270 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1-ml solution of 3 mg 0.5% hyperbaric bupivacaine + 25 microg of fentanyl
Number of subjects: 45
Study 22755270 — intervention group
Group type: COMPARATOR
Intervention: Control group (no opioid)
Number of subjects: 45
Study 19577885 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral approach
Number of subjects: 60
Study 19577885 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-lateral approach
Number of subjects: 60
Study 17001749 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-report after six and twelve months
Number of subjects: 0
Study 17001749 — intervention group
Group type: COMPARATOR
Intervention: GP records by independent investigators
Number of subjects: 0
Study 16199701 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 115
Study 16199701 — intervention group
Group type: COMPARATOR
Intervention: Nonanesthetic lubricant (control)
Number of subjects: 115
Study 16199701 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (lidocaine and control)
Number of subjects: 115
Study 11818036 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 hour workshop on Evidence Based Medicine (EBM)
Number of subjects: 83
Study 11818036 — intervention group
Group type: COMPARATOR
Intervention: Workshop on bioethics (control intervention)
Number of subjects: 83
Study 10367928 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-water irrigation (HWI)
Number of subjects: 122
Study 10367928 — intervention group
Group type: COMPARATOR
Intervention: Tamponade treatment
Number of subjects: 122
Study 8680064 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment
Number of subjects: 0
Study 8680064 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 2076247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol gum (Trident) chewed for 10 minutes after ingestion of snacks
Number of subjects: 5
Study 2076247 — intervention group
Group type: COMPARATOR
Intervention: Sucrose-containing snacks (chocolate bar, cream-filled cupcakes, cream-filled sandwich cookie, cherry pie, raisins)
Number of subjects: 5
Study 2076247 — intervention group
Group type: COMPARATOR
Intervention: Starch-containing snacks (oat cereal, granola bars, pretzels, potato chips, corn chips)
Number of subjects: 5
Study 381221 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmetin 200 mg (T 200)
Number of subjects: 20
Study 381221 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 400 mg (P 400)
Number of subjects: 20
Study 381221 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmetin 150 mg plus Paracetamol 300 mg (T 150 + P 300)
Number of subjects: 20
Study 381221 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmetin 100 mg plus Paracetamol 400 mg (T 100 + P 400)
Number of subjects: 20
Study 381221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30404563 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (300 mg/day)
Number of subjects: 60
Study 30404563 — intervention group
Group type: COMPARATOR
Intervention: Placebo (wheat starch)
Number of subjects: 60
Study 30910240 — intervention group
Group type: EXPERIMENTAL
Intervention: Verified hip fracture (HF)
Number of subjects: 449
Study 28401850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothering From the Inside Out (MIO)
Number of subjects: 87
Study 28401850 — intervention group
Group type: COMPARATOR
Intervention: Parent Education (PE)
Number of subjects: 87
Study 26073532 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT/leucovorin
Number of subjects: 67
Study 26073532 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 67
Study 23670794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 522
Study 23670794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed nuts
Number of subjects: 522
Study 23670794 — intervention group
Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 522
Study 21885886 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise intervention for 6 months, home-based, telephone-administered
Number of subjects: 50
Study 21885886 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 50
Study 19793239 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group intervention
Number of subjects: 31
Study 19793239 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 17236781 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle-sparing thoracotomy (MST)
Number of subjects: 100
Study 17236781 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral thoracotomy (PLT)
Number of subjects: 100